When he first entered college, Riqiang Yan wanted to be a doctor. But he soon changed paths when he realized how exciting the research tract was.
When I had just graduated high school, I was kind of nave. I didnt know much about the field until I came to college and became more fascinated by the research, Yan says. I wanted to make knowledge in the science part.
Yan began doing research during his undergraduate thesis project, which was trying to develop a new drug formulation for ulcer treatment at Shanghai Medical University. He was so interested in the project that he continued working on it even after his graduated, which was very unusual at that time for a student who otherwise could have enjoyed time off during the summer break. Yan credits Prof. Yuanming Ma () with providing him that opportunity, and guided him toward the research career path he eventually followed. Following this experience, Yan received his masters degree in biochemistry at Shanghai Medical University and went on to earn his Ph.D. in biochemistry at the University of Kentucky.
Yan is now one of the worlds leading Alzheimers disease researchers. He is a professor and chairman of UConn Healths Department of Neuroscience, leading discovery efforts at UConns School of Medicine. Yan came to UConn from the Cleveland Clinic in 2018. He established the first research program focused on studying Alzheimers and other forms of neurodegenerative disease in hopes of potentially discovering effective treatments.
Yans arrival at UConn also ushered in a host of research collaboration opportunities across the School of Medicine and its departments of neurology, neurosurgery, psychiatry, neurobiology, the Center on Aging, and brain investigators at the University, as well as with the Jackson Laboratory for Genomic Medicine on UConn Healths campus.
Cutting-Edge Alzheimers Research
Now a preeminent scholar in the field, Yan didnt start out doing Alzheimers research. At the beginning of his independent research career, Yan was studying inflammation in lung diseases for global pharmaceutical company Pharmacia & Upjohn. When the companys priorities changed, Yan shifted over to Alzheimers research. The neurodegenerative disease that affects an estimated 5.5 million Americans has no known cure.
I ended up in Alzheimers research by accident, Yan says. It was a very exciting time because we had so many unknown questions about Alzheimers disease to explore.
That accident turned out to be extremely productive. One year after making the switch, Yan made a breakthrough discovery.
In 1999, Yan and several other groups of researchers simultaneously discovered that an enzyme known as BACE1 plays a crucial role in the processes that lead to the onset of Alzheimers disease. BACE1 cleaves amyloid precursor proteins which give rise to beta amyloid. This peptide is the main component of plaques on brain cells, one of the culprits for causing Alzheimers disease.
From there, researchers from multiple pharmaceutical and biotech companies began developing trials of BACE1 inhibitors in hopes of stopping the effects of BACE1s activity. However, all these trials failed. While these failures were frustrating, they taught scientists an important lesson about this key enzyme; not only does BACE1 activity lead to Alzheimers disease, it is also responsible for ensuring parts of normal neural activity. By blocking it completely, the treatments did more harm than good.
Things Are Not So Simple
We still dont have a drug, Yan says, 20 years after the original discovery. These early trials with BACE1 failed because if you simply inhibit it, it interferes with necessary brain functioning. Its challenging.
Yan reflects that this is one of the most challenging aspects of his research. The human body is not simple, and neither are the diseases that afflict it. Before we can develop an effective treatment for Alzheimers disease, we need to understand how it works at a basic molecular level.
Many times, you will find out things are not so simple, Yan says. We need to understand the biology before we can have an effective drug.
Most recently, Yan published a paper in the Journal of Experimental Medicine about the role of CX3CL1, a transmembrane protein, on Alzheimers disease. Yan found that CX3CL1 is cleaved by BACE1. He also found that an overexpression of the C-terminal fragment of CX3CL1 can reduce amyloid deposition and neuron loss in mice with Alzheimers disease. This is the first time its been shown that the C-terminal CX3CL1 can aid adult neurogenesis which directly combats the neurodegeneration of Alzheimers disease.
This development of knowledge underscores the role of academic researchers in eventual drug discovery, Yan says. Developing knowledge about diseases and the workings of the human body is the foundation for future drugs.
Were in academia. Our main focus is to understand the molecule first before we try to develop a compound, Yan says.
If researchers or pharmaceutical companies go into drug trials without this critical understanding, they could encounter many harmful side effects. With a better understanding of the science behind the disease, such side effects could be better anticipated and even avoided.
Yan says researchers can help pharmaceutical companies develop more effective drugs by working in tandem with industry partners.
We may not be able to compete with the pharmaceutical companies directly in some cases, but we can do something to help the companies develop better drugs, Yan says. And thats whats more important to us.
Follow UConn Research on Twitter & LinkedIn.
Read more:
Meet the Researcher: Riqiang Yan, Neuroscience - UConn Today
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]